The human transaldolase gene (TALDO1) is located on chromosome 11 at p15.4-p15.5

Genomics

Volumn 45, Issue 1, 1997, Pages 233-238

  Banki, Katalin ^a   Eddy, Roger L ^c   Shows, Thomas B ^c   Halladay, David L ^a   Bullrich, Florencia ^d   Croce, Carlo M ^d   Jurecic, Vesna ^b   Baldini, Antonio ^b   Perl, Andras ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSALDOLASE;

ARTICLE; CHROMOSOME 11; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE MAPPING; GENOME; HUMAN; HUMAN CELL; HYBRID CELL; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0031260375     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.4932     Document Type: Article

References (21)

1. 1. Baldini, A., Ross, M., Nizetic, D., Vatcheva, R., Lindsay, E. A., Lehrach, H., and Siniscalco, M. (1992). Chromosomal assignment of human YAC clones by fluorescence in situ hybridization: Use of single yeast colony PCR and multiple labeling. Genomics 14: 181-184.
2. 2. Banki, K., Colombo, E., Sia, F., Halladay, D., Mattson, D., Tatum, A., Massa, P., Phillips, P. E., and Perl, A. (1994). Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J. Exp. Med. 180: 1649-1663.
3. 3. Banki, K., Hutter, E., Colombo, E., Gonchoroff, N. J., and Perl, A. (1996). Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression. J. Biol. Chem. 271: 32994-33001.
4. 4. Banki, K., and Perl, A. (1996). Inhibition of the catalytic activity of human transaldolase by antibodies and site-directed mutagenesis. FEBS Lett. 378: 161-165.
5. 5. Banki, K., Halladay, D., and Perl, A. (1994). Cloning and expression of the human gene for transaldolase: A novel highly repetitive element constitutes an integral part of the coding sequence. J. Biol. Chem. 269: 2847-2851.
6. 6. Baquer, N. Z., Hothersall, J. S., McLean, P., and Greenbaum, A. L. (1977). Aspects of carbohydrate metabolism in developing brain. Dev. Med. Child Neurol. 19: 81-104.
7. 7. Chomczynski, P., and Sacchi, N. (1987). Single step method of RNA isolation by acid guadinium-isothiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
8. 8. Colombo, E., Banki, K., Tatum, A. H., Daucher, J., Ferrante, P., Murray, R. S., Phillips, P. E., and Perl, A. (1997). Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J. Clin. Invest. 99: 1238-1250.
9. 9. Dowdy, S. F., Fasching, C. L., Araujo, D., Lai, K., Livanos, E., Weisman, B. E., and Stanbridge, E. J. (1991). Suppression of tumorigenicity in Wilms' tumor by the p15.5-p14 region of chromosome 11. Science 254: 293-295.
10. 10. Haines, J. L., Ter-Minassian, M., Bazyk, A., Gusella, J. F., Kim, D. J., Terwedow, H., Pericak-Vance, M. A., Rimmler, J. B., Haynes, C. S., Roses, A. D., Lee, A., Shaner, B., Menold, M., Seboun, E., Fitoussi, R., Gartioux, C., Reyes, C., Ribierre, F., Gyapay, G., Weissenbach, J., Hauser, S. L., Goodkin, D. E., Lincoln, R., Usuku, K, Garcia-Merino, A., Gatto, N., Young, S., and Oksenberg, J. R. (1996). A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genet. 13: 469-471.
11. 11. Heinrich, P. C., Morris, H. P., and Weber, G. (1976). Behavior of transaldolase (EC 2.2.1.2.) and transketolase (EC 2.2.1.1.) in normal neoplastic, differentiating, and regenerating liver. Cancer Res. 36: 3189-3197.
12. 12. Hudson, T. J., Stein, L. D., Gerety, S. S., Ma, J., Castle, A. B., Silva, J., Slonim, D. K., Baptista, R., Kruglyak, L., Xu, S., Hu, X., Colbert, A. M. E., Rosenberg, C., Reeve-Daly, M. P., Rozen, S., Hui, L., Wu, X., Vestergaard, C., Wilson, K. M., Bae, J. S., Maitra, S., Ganiatsas, S., Evans, C. E., DeAngelis, M. M., Ingalls, K. A., Nahf, R. W., Horton, L. T., Jr., Anderson, M. O., Collymore, A. J., Ye, W., Kouyoumjian, V., Zemsteva, I. S., Tam, J., Devine, R., Coutney, D. F., Renaud, M. T., Nguyen, H., O'Connor, T. J., Fizames, C., Faure, S., Gyapay, G., Dib, C., Morisette, J., Orlin, J. O., Birren, B. W., Goodman, N., Weissenbach, J., Hawkins, T. L., Foote, S., Page, D. C., and Lander, E. S. (1995). An STS-based map of the human genome. Science 270: 1945-1954.
13. 13. Kusuda, J., Hirai, M., Toyoda, A., and Hashimoto, K. (1997). Localization of the human transaldolase gene (TALDO) to chromosome 1p33-p34.1 by fluorescence in situ hybridization and PCR analysis of somatic cell hybrids. Genomics 40: 378-381.
14. 14. Mayes, P. (1993). The pentose phosphate pathway & other pathways of hexose metabolism. In "Harper's Biochemistry" (R. Murray, D. Granner, P. Mayes, and V. Rodwell, Ed.), pp. 201-211. Appleton & Lange, Norwalk, CT.
15. 15. Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., and Lane, T. E. (1993). Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151: 2132-2141.
16. 16. Novello, F., and McLean, P. (1968). The pentose phosphate pathway of glucose metabolism. Measurements of the nonoxidative reactions of the cycle. Biochem. J. 107: 775-791.
17. 17. Seizinger, B., Klinger, H. P. J., Junien, C., Nakamura, Y., Le-Beau, M., Cavenee, W., Emmanuel, B., Ponder, B., Naylor, S., Mittelman, F., Louis, D., Menon, A., Newsham, I., Decker, J., Knelbling, M., Henry, I., and Deimling, A. V. (1991). Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet. Cell Genet. 58: 1080-1096.
18. 18. Shows, T. B., Alders, M., Bennett, S., Burbee, D., Cartwright, P., Chandrasekharappa, S., Cooper, P., Courseaux, A., Davies, C., Devignes, M.-D., Devilee, P., Elliot, R., Evans, G., Fantes, J., Garner, H., Gaudray, P., Gerhard, D. S., Gessler, M., Higgins, M., Hummerich, H., James, M., Lagercrantz, J., Litt, M., Little, P., Mannens, M., Munroe, D., Nowak, N., O-Brien, S., Parker, N., Perlin, M., Reid, L., Richard, C., Sawicki, M., Swallow, D., Thakker, R., van Heyningen, V., van Schothorst, E., Vorechovsky, I., Wadelius, C., Weber, B., and Zabel, B. (1996). Report of the fifth international workshop on human chromosome 11 mapping (1996). Cytogenet. Cell Genet. 74: 1-56.
19. 19. Shows, T. B., Eddy, R., Haley, L., Byers, M., Henry, M., Fujita, T., Matsui, H., and Taniguchi, T. (1984). Interleukin 2 (IL-2) is assigned to human chromosome 4. Somat. Cell. Mol. Genet. 10: 315-318.
20. 20. Shows, T. B., Sakaguchi, A. Y., and Naylor, S. L. (1982). Mapping the human genome, cloned genes, DNA polymorphisms, and inherited diseases.. In "Advances in Human Genetics" (H. Harris and K. Hirschhorn, Eds.), pp. 341-452, Plenum, New York/ London.
21. 21. Sonoda, Y., Iizuka, M., Yasuda, J., Makino, R., Ono, T., Kayama, T., Yoshimoto, K., and Sekiya, T. (1995). Loss of heterozygosity at 11p15 in malignant glioma. Cancer Res. 55: 2166-2168.